side effects of low dose tirzepatide for Weight Loss Diabetes Drug - Tirzepatide Gets
Description
At 4 mg retatrutide / 0.8 mg cagrilintide per week (the upper end of community-reported maintenance for both), the smaller vial provides roughly 3 weeks at maintenance and the larger vial roughly 5 weeks
Our team creates unique treatment plans for every patient, depending on their goals and needs
If you are still at 2.5mg or 5mg, escalation according to the schedule may be the answer
regular monitoring is critical
